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Abstract: Kenya is home to Africa’s third largest population of dromedary camels, and production at
commercial and local levels are increasingly important. In pastoral and nomadic communities in
the arid and semi-arid lands (ASALs), camels play a vital role in food security, while commercial
milk production and formalized export markets are rapidly emerging as camel populations expand
into non-traditional areas. Until recently, little focus was placed on camels as hosts of zoonotic
disease, but the emergence of Middle Eastern respiratory coronavirus (MERS-CoV) in 2012, and the
discovery of exposure to the virus in Kenyan camels, highlighted the need for further understanding
of this area. This systematised review utilised a robust search strategy to assess the occurrence
of camel-associated zoonoses in Kenya and to evaluate the quality of the published literature.
Seventy-four studies were identified, covering sixteen pathogens, with an increasing number of good
quality studies in recent years. Despite this, the area remains under-researched and there is a lack of
robust, high-quality research. Trypanosome spp., Echinococcus granulosus and Brucella spp. appeared
most frequently in the literature. Pathogens with the highest reported prevalence were MERS-CoV
(0–100%), Echinococcus granulosa (7–60%) and Rift Valley fever virus (7–57%). Exposure to Brucella spp.,
Coxiella burnetii and Crimean-Congo haemorrhagic fever virus showed higher levels in camel or
camel-associated vectors than other livestock species, although brucellosis was the only disease for
which there was robust evidence linking camel and human exposure. Zoonotic agents with less
severe human health outcomes, such as Dermatophilosus congolensis and contagious ecthyma, were also
represented in the literature. This review provides an important summary of the scope and quality of
current knowledge. It demonstrates that further research, and improved adherence to robust study
design and reporting are essential if the zoonotic risk from camels in Kenya, and elsewhere, is to be
better understood.
Keywords: dromedary; camel; zoonoses; Kenya; systematic review
1. Introduction
Kenya is home to Africa’s third largest population of one-humped, dromedary camels
(Camelus dromedarius) and they account for approximately 5% of the country’s livestock [1].
Camel production has long played a vital role in nomadic and pastoral communities, but formalised
production, aimed primarily at lucrative urban milk markets, as well as a thriving international
export market, are increasingly important [2–5]. Camels are unique amongst livestock species in their
ability to thrive in arid environments, providing an important source of food and financial security to
vulnerable communities, particularly in the face of climate instability [6–8]. Camel keeping in Kenya
was traditionally focussed in pastoral communities in the arid and semi-arid lands (ASALs) in the
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northern and north-eastern regions, but as interest in camel production and awareness of their value in
food security has developed, populations have expanded into non-traditional areas such as Isiolo and
Laikipia; a move supported by the Kenyan government’s ‘2030 vision’ [7,9,10].
Perhaps due to their capacity to thrive in harsh environments, camels were previously considered
resistant to many diseases common in other production animals [11,12]. However, the expansion
of camel production has led to a re-evaluation of traditional assumptions regarding the species’
susceptibility to disease [13,14], and the emergence of Middle Eastern respiratory syndrome coronavirus
(MERS-CoV) in Saudi Arabia in 2012 brought their potential as a zoonotic reservoir into sharp
focus [15,16]. Zoonotic pathogens, both in Kenya and globally, disproportionally affect the poorest
communities, who tend to live in closer proximity to livestock and often have limited access to medical
and veterinary services [17,18]. The benefits of a One Health approach to zoonotic disease control,
particularly in poor and isolated communities, has become well established in Kenya over the last
decade, but research has tended to focus on cattle and small ruminants [19,20]. As camel production
expands, opportunities for zoonotic transmission events are likely to increase. Developing a better
understanding of potential zoonotic hazards is an important first step towards reducing the frequency
and impact of these events. In light of these concerns, a systematic evaluation of the literature was
undertaken to assess the occurrence of zoonotic pathogens associated with dromedary camels in Kenya,
and the scope of the published literature. The aims of the review were to evaluate the scope and quality
of the literature, as well as to collate prevalence and strain-typing data, with a view to identifying gaps
in current knowledge and priorities for future research.
2. Materials and Methods
2.1. Search Strategy and Record Assessment
A systematised review of the literature was carried out, taking into consideration the guidelines
set out in the PRISMA statement, and by adapting best-practice guidelines and protocols developed by
other systematic review reporting systems [21–26]. Nine databases and collections relating to medical
and veterinary disease, global health and basic science were searched to provide a comprehensive
assessment of published literature (CAB abstracts, Global Health, Medline, PubMed, Web of Science,
BIOSIS, EMBASE, Zoological Record and Africa-Wide Information). Searches covered publications up
to the end of December 2017. Grey literature, including media articles and unpublished government
reports were excluded due to difficulties in verifying their contents, and comprehensively searching
for them.
Zoonotic infections of camels deemed likely to be of relevance in Kenya were determined through
review of camel health and production literature, literature relating to zoonoses of other livestock
species in East Africa, and the Kenyan Government Zoonotic Disease Unit’s list of priority zoonoses [27].
Only pathogens that could cause clinical disease in humans and be transmitted via human/camel
contact, close association such as via aerosol or fomite spread, or by vector transmission were included.
This excluded most food-borne pathogens including Escherichia coli and Salmonella species.
Search terms defining the population, location and disease exposure were combined using the
Boolean operator “AND”, and Boolean syntax was adapted to the requirements of the different databases.
Terms relating to population included “camel/camels” and “dromedary/dromedaries”. Location terms
used were “Kenya” and “Kenyan.” For disease terms, “zoono*” was combined using the Boolean
operator ‘OR’ with terms relating to individual zoonotic diseases of camels. Trypanosoma species (spp.)
were included due to recent evidence of the zoonotic potential of Trypanosoma evansi [28–30]. Population,
location and disease searches were combined using the Boolean operator “AND”. A full list of diseases
identified, and the basic search terms used are presented in Table 1. Search terms and inclusion criteria
were reviewed by both authors prior to commencement of searches, and review was undertaken by
the first author only.
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Table 1. Search terms and synonyms used to construct searches relating to zoonotic pathogens of
camels in Kenya.
Zoonotic Infections/Agents of Relevance Search Terms and Synonyms (* Indicates Wildcard Search Function)
Brucella spp. “brucel *”
Camelpox “camelpox”, “pox” “poxvir *”, “orthopox *”
Crimean-Congo haemorrhagic fever virus “Crimean-Congo haemorrhagic fever *”
Echinococcus granulosa sensu lato “echinococ *”, “* hydatid *”
Emerging pathogens “emerging” AND “infection *” OR “virus *” OR “bacteria *”
Middle Eastern respiratory syndrome virus “Middle East respiratory”, “Middle Eastern respiratory”, “MERS”,“MERS-CoV”, “coronavir *”
Q fever (Coxiella burnetii) “q fever *”, “coxiell *”
Rift Valley fever virus “Rift Valley fever”, “RVF”
Sarcoptes “sarcopt *”, “mange *”
Toxoplasmosis “toxoplasma *”
Trypanosome spp. “* trypanos *”, “African trypan *”
Tuberculosis “TB”, “tubercul *”, “mycobact *”
Wildcard functions (denoted by an *) were used to expand the search terms where appropriate. Search terms and
wildcard functions were adapted as required for each database.
Citations were compiled in EndNoteTM and duplicate entries removed. Remaining titles and
abstracts were subject to three levels of review: (i) title and abstract review, (ii) full-text review and
(iii) quality review. At each stage, citations, abstract or full-text papers were included or excluded
according to predefined criteria (Supplementary Materials, Figures S1 and S2). Data were extracted
from the remaining full-text citations using a standard data extraction form and the details entered
into Microsoft Excel (2016). Where citations were published in more than one location, the more recent
or more complete citation was selected. During the full-text review, reference lists of relevant papers
were searched by hand and additional papers added.
2.2. Quality Criteria Assessment
The quality criteria set out in Alonso et al. [24] were used to assess the level of bias in the full-text
review papers. An adapted version of the Alonso et al. criteria is presented in Table 2. All papers,
regardless of quality designation were included in the qualitative review and discussion. For the
purposes of presenting quantitative data on prevalence, only data from papers deemed to be of medium
or good quality were reported [24].
Table 2. Quality criteria tool used to assess the level of bias in studies selected for inclusion in the
review. Adapted from [24].
Good Quality (Low Risk of Bias) Medium Quality (Moderate Risk of Bias) Poor Quality (High Risk of Bias)
Unbiased selection of subjects,
evidence of randomisation
Bias in subject selection is acknowledged and
accounted for or is unavoidable
Bias in subject selection is not
acknowledge or accounted for
Appropriate data analysis Data analysis limitations are acknowledged Inappropriate data analysis
Scientifically sound methods Methods are sound but may not be themost appropriate Methods are inappropriate
Accurately described methods Methods are comprehensible and valid evenif details are lacking Methods are unclear or incomplete
Accurate and complete reporting of results Results are reported accurately Results are inaccurate or incomplete
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3. Results
3.1. Summary
Following the three stages of review, 74 unique studies were identified as fitting all pre-defined
criteria (Supplementary Materials, Figures S1 and S2). The PRISMA flow diagram, showing the
numbers of references identified and removed at each stage, is shown in Figure 1.
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Twenty-four papers (32.4%) were deemed to be of poor quality, 41 (55.4%) medium and nine
(12.2%) of good quality. All but one of the good quality studies were published since 2000, with a
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trend towards an increasing proportion of good or medium quality publications and a decrease in
poor quality studies over the course of the review (Figure 2).
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Figure 2. Percentage of total studies per decade categorised as good, medium or poor quality based on
the criteria set out by Alonso et al. [24].
Sixteen pathogens, or genera of pathogens, were identified: thirteen in camel hosts, four in ticks
retrieved from camels, and two camel-specific strains of pathogen identified in humans (Table 3).
Eight viruses, five bacteria, one protozoa, one fungus and one endoparasite were identified. The largest
number of papers (n = 29, 39.2%) dealt with trypanosome species, with the next most frequently
reported pathogens being Echinococcus spp. (n = 9, 12.2 ) and Brucella spp. (n = 7, 9.5%). Five studies
were published before 1980, with between 16 and 20 studies published in each decade since. Zoonotic
potential was specifically mentioned in 29 papers (39.1%) and an increase in such studies was observed
since 2010, with all papers since this date highlighting zoonotic risk (Figure 3). Forty-two studies dealt
with disease surveillance (56.8%), with the majority of these employing a cross-sectional design to
determine prevalence.
Prevalence figures reported in medium- and good-quality papers are reproduced in Table 4.
Strain typing and pathogen characterisation was the focus of 17 (23.0%) studies and diagnostic test
development or validation accounted for 13 (17.6%) publications. The remaining studies included
treatment trials, risk evaluations, disease impact and disease outbreak investigations or case studies.
Half of identified papers (n = 37) referred to a county level location. Figure 4 shows the number of
studies by county.
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Table 3. Zoonotic pathogens of dromedary camels in Kenya: number of studies identified in this review and host species in which it was identified.
Pathogen or Disease Number of Studies
Host or Vector of the Pathogen Identified
References
Quality Score
Camel Tick † Human ‡ Good Medium Poor
Viruses
MERS-CoV 4 X X [32,33] [34,35]
Rift Valley fever virus 4 X [36,37] [38,39]
Camelpox 4 X [40,41] [42,43]
Crimea-Congo haemorrhagic fever virus 2 X X [44,45]
Contagious ecthyma 2 X [46,47]
Dugbe virus 1 X [48]
Dhori virus 1 X [48]
Influenza viruses (ICV and IDV) 1 X [49]
Bacteria
Coxiella burnetii (Q fever) 3 X [50,51] [52]
Dermatophilus congolensis 5 X [53] [54–57]
Brucella spp. 7 X [58] [59] [12,60–63]
Mycobacterium spp. 1 X [60]
Rickettsia spp. 1 X [64]
Parasites and Fungi
Trypanosoma spp. 28 X [65–69] [10,70–83] [84–92]
Echinococcus spp. 10 X X [93] [94–102]
Trichophyton verrucosum 1 X [53]
† Ticks removed from Dromedary camel hosts only. ‡ Evidence of transmission from camels to human, or of a camel-specific strain of pathogen in human hosts.
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3.2. Viruses
Half the zoonotic hazards identified were viruses, with MERS-CoV, Rift Valley fever (RVF) virus
(RVFV) nd camelp x the most commonly described (Table 3). E S- was the focus of four eligible
good- and medium-quality papers betwee 2014 and 2017. All publications described cross-sectional
stud es to determine current or historic serological exposure to MERS-CoV in camel or humans,
with the most recent study examining xp sure in linked camel nd human p pulations [33]. Prevalence
esti te in camels ranged from 6.1% to 100% depending on diagnostic method, age and locati n [33–35].
Liljander et al. found 0.18% of hu ans teste positive for MERS-CoV specific a tibodies, but no umans
s mp ed in the linked household study were positive by the same diagnos c method (Table 4) [32,33].
RVF was also the focus of four p pers, two of poor and tw of medium quality (Table 3). Early evidence
indicated that RVFV w s the cause of camel abortions during the 1961–1962 epidemic, confirming the
presence of the virus in the arid northern counties [38,39]. Both medium-quality papers demonst ated
high seroprevalence during the 2006–2007 epidemic, with Britch et al. [37] also reporti g a pre-epidemic
prevalence of approximately 7% (Tabl 4). Ca elpox was the focus of four studies, with two of medium
quality. One repor ed a cross-secti nal survey (Table 4), and one employed a variety of laboratory
techniqu s t characterise two strains of Kenyan camelpox [40,41]. No studies have been published
on camelpox in Kenya since 1997 [40]. Contagious cthyma, caused by a parapox virus [103,104],
was rep rted in camels in two medium quality studi s. One reported on an outbr ak of clinical
disease in Laikipia in 1984 [47], while the othe presented results of a cros -s ctional survey in Turkana
(Table 4) [46].
Crimean-Congo haem rrhagic fever viru (CCHFV) w s the focus of two studies, both of
medium qu lity. One found evidenc of exposure in camels imported from Kenya to Egypt [45]
(Table 4), whi e the second used reverse transcription PCR (RT-PCR) to sc een ticks collected from
livestock in north-east rn Kenya in 2008 [44,45]. Five tick pools were positive for CCHFV (1.4%) [44].
Morrill. et al. also t sted samples for antigenically related Nairoviruses, including Dugbe virus [105],
which was so de c in ticks fr m cam ls in Garissa and Isiolo in a survey of tick-borne viruses
between 2007 and 2010 [45,48]. Nine percent of tick pools positive for Dugbe virus came from
camel hosts. Dhori virus, a zoonotic orthomyxovirus, was identified in ticks pooled from a camel
in Isiolo, and Kupe virus, which is of unknown pathogenicity in humans, was detected in the same
study [48,106,107]. A single paper investigating the seroprevalence of Influenza D and C viruses
(IDV and ICV) in livestock found antibodies to one or other of the viruses in almost all Kenyan camels
sampled, with evidence of cross-reactivity between IDV and ICV (Table 4) [49].
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Table 4. Prevalence values reported in disease surveillance studies categorised as good or medium quality, based on criteria set out in Alonso et al. 2016 [24].
Type Pathogen Species Dates Sampled Test Used Number Tested County or Region Prevalence % (95% CI) † Quality Reference
Virus
Middle Eastern respiratory
coronavirus (MERS-CoV)
Camel 1992–2013
Recombinant MERS-CoV spike protein subunit 1-based
ELISA (rELISA) described by Memish et al., 2014 [109]
162 North-eastern region 56.2
Medium [34]154 Eastern region 17–100
458 Rift Valley region 0–18
Camels 2013 Spike protein subunit 1 protein microarray [110,111] 335 Laikipia county 46.9 Medium [35]
Camels
2013
AntiMERS-CoV Camel IgG ELISA kit
(EUROIMMUN AG, Lübeck, Germany) 879 Marsabit county 90 (95% CI 88–92)
Good [33]
Humans
AntiMERS-CoV Camel IgG ELISA kit (EUROIMMUN
AG, Lübeck, Germany) followed by plaque reduction
neutralisation test (PRNT) [112]
760 Marsabit county 0
Humans 2013–2014
rELISA (EUROIMMUN AG, Lübeck, Germany)
followed by PRNT [112]
559 Garissa county 0
Good [32]
563 Tana River county 0.36
Crimean-Congo
haemorrhagic fever virus Camels 1986–1987 Agar gel diffusion (AGD) test [113] 499 Not specified 26 Medium [45]
Contagious ecthyma Camels Not specified Clinical examination and electron microscopy 600 Turkana 11.2 Medium [46]
Rift Valley fever virus
Camels 2006–2007 (epidemic period) In-house IgG ELISA [114] 110 Not specified 20.9 Medium [36]
Camels
2000 (pre-epidemic period)
In-house inhibition ELISA [115]
15 Galana county 6.7
Medium [37]13 Garissa county 7.7
2007 (epidemic period) 28 Isiolo county 57.1
Camelpox Camels 1992 Clinical examination, electron microscopy,
virus neutralisation
1000 Samburu county 27
Medium [40]
1200 Turkana county 6
Influenza D virus (IDV) Camels 2015 Hemagglutination inhibition (HI),post-ICV hemadsorption 293 Not specified 8.2 Medium [49]
Influenza C virus (ICV) Camels 2015 HI, post-IDV hemadsorption 293 Not specified 10.6 Medium [49]
Bacteria
Brucella spp.
Camels Not specified
Rose Bengal plate test (RBPT)
174 Warir, Garissa and
Mandera counties
4.6
Medium [59]Serum agglutination test (SAT) 10.34
Complement fixation test (CFT) 9.77
Camels 2013 Brucella-Ab C-ELISA kit(SVANOVIR, Uppsala, Sweden) 1605 Marsabit county 11.1 (95% CI 9.4–15.0) Good [108]
Coxiella burnetii (Q fever)
Camels 2011 ELISA CHEKIT Q fever test kit(IDEXX, Westbrook, ME, USA 72 Laikipia county
Adults
(3–9 years) 46
Young
(<6 m)
5
Medium [50]
Camels 2013 ELISA CHEKIT Q fever test kit(IDEXX, Hoofddorp, The Netherlands) 334 Laikipia county 19 Medium [51]
Dermatophilus congolensis Camels 1993 Clinical examination and bacterial isolation
3200 Samburu county Wet season, 20.9Dry season, 13.6
Medium [53]
600 Laikipia county Wet season, 22.7Dry season, 14.3
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Table 4. Cont.
Type Pathogen Species Dates Sampled Test Used Number Tested County or Region Prevalence % (95% CI) † Quality Reference
Parasites
Echinococcus spp.
Camels 1998–2000 Post-mortem examinations 70 Turkana county 60.1 Medium [102]
Camels 2013 Post-mortem examination and RFLP-PCR [98] 219 Meru and Isiolo counties 6.94 Medium [98]
Trypanosoma spp.
Camels 1996–1997
Haematocrit centrifugation technique (HCT)
Mouse inoculation test (MIT)
Suratex® latex agglutination test
(Brentec Diagnostics, Nairobi, Kenya) [71]
103 Athi River (Machakos county) 2.9 (95% CI 0–6.2)
Medium [73]749 Isiolo county 25.4 (95% CI 22.3–28.5)
86 Mugwoni (Laikipia county) 18.6 (95% CI 10.4–26.8)
Camels Not specified Phase contrast buffy coat technique (BCT)MIT 347 Kajiado county 33.8 Medium [10]
† 95% confidence intervals (95% CI) only reproduced here if reported in the original study.
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3.3. Bacteria
Five bacterial pathogens associated with camel hosts were identified (Table 3). Brucella spp. were
reported in seven eligible papers, covering ten counties, between 1978 and 2015 (Table 3). All studies
reported serological evidence of exposure, with a single study examining seropositivity in humans and
livestock [108]. Two papers reporting cross-sectional surveillance were of medium or good quality
(Table 4) [59,108]. Exposure to Coxiella burnetii, the causative agent of Q fever, was the focus of three
eligible studies (Table 3). One paper, of poor quality, identified four positive camels in Samburu [52]
and two medium quality studies investigated prevalence in camels in Laikipia in 2011 and 2013 [50,51].
Skin conditions caused by Dermatophilus congolensis were reported in five studies in Laikipia, Samburu
and Turkana counties, one of which was of medium quality [53]. The presence of five Rickettsia
species in ticks removed from camels was reported in a single cross-sectional study in pastoralist areas
of Garissa and Isiolo counties [64]. Sixty percent of positive tick pools were collected from camels,
compared to 31% from cattle, 17% from sheep and 14% from goats. A single study, deemed to be of
poor quality, indicated the presence of Mycobacteria spp. in camels ranched between Tana River and
Kilifi Counties [60]. Fifteen camels (36.6%) reacted following the intradermal skin test and acid-fast
bacteria were detected on impression smears from a single lung lesion.
3.4. Parasites and Fungi
One endoparasite, one protozoa and one fungi were identified in the literature (Table 3).
Cystic echinococcus, caused by the dog tapeworm Echinococcus granulosus sensu lato (s.l.) was
reported in ten studies. Where county location was specified, all but one focussed on Turkana [98].
One study reported only human infection while all other studies reported infection in camels and
other livestock species [99]. Eight studies presented strain or genetic typing evidence (Table 5),
while cross-sectional disease surveillance data were presented in two publications (Table 4) [98,102].
All studies were of medium or good quality. Studies concerned various species and strains of
E. granulosus sensu lato. The categorisation of E. granulosus has changed considerably over the period
of the review and three different categorisation systems are represented in the eligible papers (Table 5).
Trypanosoma spp. were the focus of the largest number of studies (n = 28). All papers investigated the
presence of Trypanosoma brucei-type (trypanozoon) organisms and 26 confirmed T. evansi specifically.
Although one study specified a potential zoonotic risk from T. evansi, no typanosome species responsible
for typical human African trypanosomiasis (HAT) were identified. A single study presented evidence of
mixed infections with Dermatophilus congolensis and Trichophyton verrucosum, a zoonotic dermatophyte
fungal pathogen [53].
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Table 5. Echinococcus granulosus sensu lato characterised according to the nomenclature set out in each
paper to describe strain, species and genotype, with host species and diagnostic method reported.
Echinococcus granulosus
Species/Genotype Host Species Method of Confirmation County/Location Reference
E. granulosus
Type B Camel Electrophoresis: isoelectric focusing Turkana [97]
E. granulosus
Type A Human Electrophoresis: isoelectric focusing Turkana [97]
E. granulosus
‘Common sheep strain’ Camel PCR and electrophoresis Turkana [100]
E. granulosus
‘Camel strain’ Camel PCR and electrophoresis Turkana [100]
E. granulosus G1 CamelHumans PCR Turkana/Maasai [116]
E. granulosus G6 (G6/7) CamelHuman PCR Turkana/Maasai [116]
E. granulosus G1 Human PCR Turkana [99]
E. granulosus G6 Human PCR Turkana [99]
E. granulosus sensu stricto
(s.s.) Camel PCR Meru/Isiolo [98]
E. canadensis (formally G7) Camel PCR Meru/Isiolo [98]
E. Canadensis G6/7 cluster CamelsHuman PCR Not specified [93]
4. Discussion
This review documented evidence of 16 zoonotic pathogens in dromedary camels in Kenya.
The pathogens with the highest reported prevalence in camel populations were MERS-CoV,
Echinococcus granulosa s.l. and RVFV, while Brucella spp., Coxiella burnetii and CCHFV showed
higher levels in camels or camel-associated vectors than other livestock species (Table 4). Brucellosis
was the only pathogen for which robust evidence was identified linking camels with increased human
disease risk, although a lack of evidence for this link in other pathogens may be due to insufficient
research rather than an absence of association [108].
4.1. Trends in Camel Research
Livestock census and aerial estimates indicate that camel populations have expanded over the
last 30 years and the increasing importance of camel production to the Kenyan economy is widely
accepted [14,117–119]. In contrast, publication numbers of eligible studies remained broadly similar in
each decade since the 1980s, indicating that camel zoonoses research in Kenya has not increased in
line with population expansion [120,121]. However, the proportion of papers that explicitly referred
to zoonotic risk have shown a substantial increase since 2010 (Figure 2), suggesting an increasing
importance placed on this dynamic. The proportion of studies characterised as medium or good
quality also increased over the period of the review (Figure 2), which may in part reflect the emergence
of veterinary epidemiology as a distinct field of study. Prior to the most recent decades, nearly half
of identified publications were of poor quality, with small sample sizes, a lack of clear sampling
frame, or incomplete reporting of results preventing many studies from providing robust estimates
of prevalence, even where these figures were recorded. A propensity towards poor-quality research
in zoonotic disease studies has been identified elsewhere, and deserves greater attention at research
and government level to improve the quality of camel studies in general, and of camel zoonoses in
particular [24]. It is vital that high-quality research is available to enable policy makers and other
stakeholders to make appropriate decisions about zoonotic disease priorities, controls and preventions.
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4.2. Study Locations
The location of studies partly reflects the distribution of camel populations, with more studies
focusing on counties in the northern regions of the country (Figure 4). However, research location was
dominated by Laikipia, despite it being a non-traditional camel keeping area. The semi-arid county is
one of the most important in Kenya for wildlife and has a mixture of large commercial ranches, wildlife
conservancy and pastoralist lands [122]. It is easily accessible compared to counties further north and
has a history of livestock research and improvements, which may account for its overrepresentation in
the literature [50]. In addition, the Laikipia camel population is estimated to have increased by a factor
of nearly five between 1982 and 2010 and is likely to keep expanding as it is also home to the country’s
only large commercial camel dairy [50]. By contrast, counties such as Mandera and Wajir, which have
both the highest camel populations and largest proportions of the population living under the poverty
line, are under-represented in the literature [123]. Logistic and security issues may deter researchers
from undertaking projects in these areas. Somali pastoralists and other communities in this region
may be at greater risk of camel-associated zoonoses due to higher camel densities and poor access to
medical and veterinary services. The lack of published research in these areas suggests that those who
rely most heavily on camels for their health and livelihoods may be receiving the least benefit from
current research.
4.3. Viral Zoonoses
MERS-CoV is the most prominent camel associated zoonosis worldwide and has caused more than
800 deaths since it emerged in Saudi Arabia in 2012 [124]. Dromedary camels are the principal reservoir
host and several camel to human transmission events have been confirmed in the Middle East [125,126].
The papers identified in this review show strong evidence of high MERS-CoV seroprevalence in
camels in northern and north-eastern Kenya and Laikipia County as far back as 1983, suggesting
the virus is endemic in the national herd [34,127]. This is consistent with studies from across the
continent [111,127–130]. The first evidence of human exposure to MER-CoV in Sub-Saharan Africa
was reported in Tana River County by Liljander et al. in 2016 [32]. The human seroprevalence in
this study was similar to that found in Saudi Arabia [112] and may suggest that human clinical
cases are going unreported in Kenya. However, the lack of evidence for human seroconversion in
households where camel herds had very high seroprevalence found by Munyua et al. in 2017 suggests
camel to human transmissibility of MERS-CoV may be lower in Kenya compared to populations
with similar camel exposure in the Middle East [33]. The mechanisms for this apparent difference in
transmission risk remain unclear and the emergence of MERS-CoV in human populations in Kenya is
still of concern [131,132].
Rift Valley fever is a significant public health concern and is recognised as one of the top priorities
for zoonotic disease research and control in Kenya [27,133]. Evidence of clinical disease and high
levels of seroconversion in camels identified by this review suggest that camels may play an important
role in amplification and maintenance of the virus [37,38]. Similar findings from other outbreaks
across Africa support this theory, and suggest that camels may be particularly sensitive indicators of
RVFV activity, in part due to their long-distance movements as well as their apparent sensitivity to
the virus [39,134–136]. With raised awareness amongst pastoralist camel-keepers it is possible that
camel abortion could act as an early warning of RVF virus infection [137]. Investigations into the
potential role of camels in viral amplification and as sentinels are currently limited and this gap should
be addressed in future studies.
Camelpox virus is reportedly endemic in East Africa [138,139] and several studies that fell
outside the inclusion criteria of this review reported clinical outbreaks or high seroprevalence [12,139].
These observations were rarely supported by robust study design or laboratory diagnosis, making
assessment of the true burden difficult, while the zoonotic nature of camelpox is poorly understood
and rarely cited [41]. No cases of human disease have been recorded in Kenya, although
Davies et al. reported unconfirmed descriptions of humans developing ulcers on the lips and mouth
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following consumption of milk from visibly affected camels [41]. Early literature suggested that
zoonotic transmission of the virus was rare and did not present a public health concern [138,140],
but more recently, verified human cases have led to a reassessment of its zoonotic potential [141–143].
In the post-smallpox world, with the emergence of a strain of zoonotic orthopox virus a possibility [144],
further surveillance and epidemiological investigation of camelpox would be wise [141].
Crimean-Congo haemorrhagic fever virus (CCHFV) is a globally under-researched tick-borne
virus with a high case-fatality rate in humans and potential for human-human transmission [145,146].
The first human infection in Kenya, a single acute case, was reported in 2002, and in 2012 a study in Ijara
(now Garissa County) found a seroprevalence of 19% (95% CI 15–22%) in febrile patients presenting
to local health facilities [145,147]. Hyalomma spp. ticks are the principal vectors and are found on all
major livestock species in Kenya including camels [44,48]. The exact role of different livestock species
remains unclear, but CCHFV positive ticks were only obtained from cattle and camels, suggesting
these species may be involved in disease transmission and amplification. Camels may be a particularly
important focus for research given their potential to transport infected ticks over long distances.
Findings reported by Salem et al. suggest, for the first time, that camels appear to be hosts of
Influenza C and possibly Influenza D viruses (ICV and IDV) [49]. ICV is a known human pathogen,
typically causing mild disease in young patients and has been found in other mammalian species
including pigs and domestic dogs, while the host tropism of IDV is less well understood [148–150].
Although cross-reactivity between the two viruses made estimates of true prevalence difficult to
determine, the evidence presented by Salem et al. gives reason to further investigate the role of camels
in the tropism of these viruses [49].
4.4. Bacterial Zoonoses
Brucellosis is one of the most widespread and significant bacterial zoonoses worldwide, causing
severe disease in humans and livestock, as well as imposing a substantial economic burden [151,152].
Serological evidence of Brucella exposure in camels was first reported in Kenya in 1978 but despite
a prevalence of approximately 10%, no further studies investigated the pathogen in camels until
2012 [59,61,63]. The study conducted by Osoro et al. in 2015 is worthy of note as the only paper reviewed
to find an explicit link between camel exposure and increased odds of human seroprevalence [108].
Human studies indicate that the burden of disease in camel-producing regions is high. A study in
remote hospitals in Garissa and Wajir found that 13.7% febrile patients were positive for Brucella abortus
and contact with multiple animal species was significantly associated with infection [151]. Evidence
of association between humans and animals in the same household demonstrates the value to be
gained from a One Health approach, and the association with camel ownership suggests that a
potential source of Brucella infection may be overlooked in typical studies focusing on cattle and
small ruminants [108,153]. Similar studies, investigating how human interactions with camels
influence zoonotic disease risk, should be prioritised. The findings of this review also indicate that
Coxiella burnetii, the causative agent of Q fever, may be another neglected bacterial zoonosis of camels
in Kenya. C. burnetii exposure is widespread amongst livestock and humans in the country but is
poorly understood and under-reported [154]. Only two recent studies have investigated C. burnetii
in Kenyan camels but the significantly higher camel seroprevalence compared to cattle found by
Browne et al. [50] is consistent with findings from elsewhere in Africa [155].
A number of other bacterial pathogens were identified. Dermatophilus congolensis causes exudative
dermatitis in multiple species and is typically associated with tick and biting fly-transmission, although
it can also be spread by contact [156–159]. Prevalence levels were similar in Kenya to Sudan and Iran,
at between 12 and 30%, and were significantly higher during the wet season [53,160,161]. This may
indicate an increased risk as camel production moves into areas with higher rainfall. Human cases are
reported sporadically in the medical literature, but none have been reported in Kenya [157,162,163].
The typically self-limiting presentation of the disease in humans is likely to mean that cases go
unreported. However, disease can be more serious and debilitating in certain individuals, so health
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professionals working with livestock keepers should remain vigilant [164]. Rickettsia spp. were
identified from various species of ticks in Garissa and Isiolo counties and although full numbers were
not reported, significantly more Rickettsia positive tick pools came from camel-associated ticks than
other livestock hosts [64]. Despite evidence of circulation of several zoonotic Rickettsia spp. in Kenya,
few acute human clinical cases have been recorded [165–167]. However, the lack of distinct clinical
features as well poor access to laboratory diagnostics means febrile illness caused by Rickettsia spp. is
likely under-reported [64,168]. Further surveillance is required to develop a fuller picture of the true
prevalence and range of Rickettsia spp. in camel ecto-parasite populations, and the impact of these on
human disease risk. The identification of mycobacteria infections in camels, although only identified
in one study [60], may be of public health importance as Mycobacterium bovis cases have been reported
in camels elsewhere in Africa and nomadic communities in Kenya appear to have higher levels of
tuberculosis than the general population [169,170]. Although the reasons behind these high infection
rates are poorly understood, it is hypothesised to relate to consumption of infected milk. Given the
nutritional and economic importance of camel milk for many Kenyan pastoralists, further research on
the presence of zoonotic Mycobacterium species in camels, particularly in these vulnerable communities,
is recommended [118,119].
4.5. Parasitic Zoonoses
Extensive research into cystic echinococcosis (CE), caused by species of the canine tapeworm
Echinococcus granulosa s.l., has been undertaken in Kenya, and studies in this review demonstrate
the presence of E. granulosa s.l. and E. canadensis in camel populations in Turkana, Meru and Isiolo
counties. Studies tended to focus on strain typing and cyst viability rather than prevalence due to a
lack of reliable and cost-effective diagnostic tests for screening large numbers of animals under field
conditions [102,171]. Human infections, both worldwide and in Kenya, are dominated by genotype
type G1 (‘common sheep strain’), now categorized as E. granulosus sensu stricto (s.s.) [172]. Although
prevalence levels appear to be high in Kenya and neighbouring countries, the dominance of the ‘G6/G7’
genotype (now re-categorized as a distinct species, Echinococcus canadensis) in camel populations
may suggest that this species plays a lesser role in human CE [93,173,174]. However, a review of
1661 human cases globally found that 11% of these were caused by ‘G6/G7’ genotype, and a study
of animal and human cases in Sudan found that E. canadensis was the dominant cause of human
infections [175,176]. These findings suggest that E. canadensis may play a more important role in human
infection in Kenya than is currently recognised. Historically, research focussed almost exclusively
on Turkana County, where unusually high levels of CE are found in the human population [177,178].
Prevalence of Echinococcus spp. in camels in Turkana was comparable to that seen in other species, but a
slaughter slab study in Isiolo and Meru counties, where levels of CE in the human population are much
lower, found camels to have higher levels of infection compared to cattle, sheep and goats [98,102].
The dominance of Turkana as a focus of research may mean that the causes and dynamics of infection
in other areas of the country are overlooked.
The greatest number of eligible studies dealt with Trypanosoma spp., either identified specifically
as T. evansi or more generally as T. brucei-type trypanosomes, which in camel hosts are most likely to
be T. evansi. Trypanosomiasis, or Surra, caused by T. evansi is considered one of the most important
production diseases of camels in East Africa [80,179] but camels are not known to be hosts of
T. brucei gambiense or T. brucei rhodesiense, the species responsible for HAT. Trypanosomes were included
in this review due to the recently highlighted zoonotic potential of T. evansi but only one study made
explicit reference to this [68]. This is consistent with the assumption, until recently, that T. evansi was
not zoonotic. The first reported case of zoonotic T. evansi infection occurred in an Indian farmer in
2004 [180] and since then individual cases have been reported in Egypt and Vietnam [30,181]. Factors
affecting the transmissibility of T. evansi to humans are not fully understood and the risk is likely to
be very low [182]. However, given the importance of T. evansi as a production disease of camels, it is
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possible that occasional cases of human T. evansi infections occur in Kenya, but go unreported, and it’s
zoonotic potential should not be ignored [29,183].
4.6. ‘Missing’ Pathogens
Several zoonotic pathogens of camels were notable by their absence. Sarcoptic mange, caused by
the mite Sarcoptes scabii, has been listed as an important disease of camels in East Africa and was ranked
as one of the top 15 priority zoonoses in Kenya, but no eligible papers referred to this pathogen [10,133].
Cases of mange were described in several studies but these were not included because the diagnosis was
based on clinical examination only and not confirmed with appropriate laboratory methods, or because
results were incompletely reported [10,88,92]. Studies utilising more robust diagnostic methods would
help to characterise this disease risk. No publications were identified relating to Toxoplasma gondii,
which is known to be an important disease of camels elsewhere and is an under-researched but likely
important public health concern in Kenya [184]. A review and meta-analysis of toxoplasmosis in meat
animals in Africa found camels to have the highest average prevalence at 36% (95% CI 18–56%) [185],
and a study in Ethiopia found a prevalence in camels of 68.2% (95% CI: 63.5% to 72.9%) with the
presence of cats or wild felids significantly associated with camel seropositivity [186]. With camel
populations increasing in wildlife areas such as Laikipia, further research is needed to determine
the significance of this pathogen. A recent publication identified for the first time a prion disease of
dromedary camels in Algeria [187]. Although the distribution, and infectious and zoonotic risk of
this pathogen is unknown, this discovery provides further evidence of the importance of enhanced
surveillance and research into camel disease.
4.7. Limitations
The current review has certain limitations, in light of which the results should be viewed.
The exclusion of food-borne pathogens omitted a number of important camel-associated zoonoses
which would benefit from a comprehensive review, particularly in light of raw camel milk
consumption practiced in some pastoral communities [188,189]. Although efforts were taken to construct
comprehensive and replicable searches of the published literature, the exclusion of unpublished
reports and other grey literature may mean instances of disease outbreaks have been missed.
Efforts were made to standardize the quality review process by employing the methods set out
in Alonso et al., but subjectivity in this assessment may have introduced a reporting bias [24,190].
To limit bias introduced from poor quality studies, prevalence estimates were only reproduced from
medium- or good-quality papers. Although serology is an important tool in disease surveillance,
seropositivity may not reflect current infection status or transmissibility of the pathogen. In addition,
the number of identified studies does not necessarily reflect the pathogens with the highest prevalence
in camels or those that pose the greatest zoonotic risk. No further statistical analysis of the reported
data were undertaken, so it was not possible to draw conclusions about camel associated risk beyond
those presented by individual publications. Despite these limitations, the evidence identified by
this review provides a starting point for further research aimed at quantifying the risk to human
populations from camel-associated zoonoses in Kenya.
5. Conclusions
The quality findings of this review and the imbalance of research focus are reflective of
neglected tropical diseases on a wider scale, whose neglect is often driven by under-reporting
and under-estimation of true burden. Good-quality, robust studies on the prevalence, incidence or
typing of zoonotic pathogens in camels were limited, and it is vital that camel and zoonotic disease
researchers make robust study design and reporting a priority if data are to be useful for the broad
interpretation required to inform policy. Where prevalence data were robustly reported, MERS was
not the only pathogen to which camels were highly exposed, and these pathogens, as well as those
to which camels appeared more exposed than other livestock species, point to priorities for further
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research. The number of studies which considered camel and human disease together was extremely
limited, a situation also reflected in literature on other species in Kenya [191]. It remains to be seen
whether the increasing interest in One Health approaches to zoonotic disease research and control will
increase the proportion of such studies in future.
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